Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections

Sexually Transmitted Diseases

Volumn 31, Issue 9, 2004, Pages 561-567

  Morrison, Charles S ^a   Bright, Patricia ^a,b   Wong, Emelita L ^a   Kwok, Cynthia ^a   Yacobson, Irina ^a   Gaydos, Charlotte A ^c   Tucker, Heidi T ^a   Blumenthal, Paul D ^c,d  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b IL   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Planned Parenthood of Maryland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CHLAMYDIASIS; COHORT ANALYSIS; DRUG USE; ECTOPIC TISSUE; FAMILY SIZE; FEMALE; GONORRHEA; HEALTH CENTER; HORMONAL CONTRACEPTION; HUMAN; HUMAN CELL; INFECTION RISK; INFECTION SENSITIVITY; INTERVIEW; MAJOR CLINICAL STUDY; NULLIPARA; PHYSICAL EXAMINATION; REPRODUCTIVE HEALTH CENTER; UNITED STATES; UTERINE CERVICITIS; UTERINE CERVIX ECTOPY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BALTIMORE; CERVIX UTERI; COHORT STUDIES; CONTRACEPTION; CONTRACEPTIVES, ORAL, HORMONAL; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; PROSPECTIVE STUDIES; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL DISEASES;

EID: 4344600621     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000137904.56037.70     Document Type: Article

References (29)

1. World Health Organization Department of HIV/AIDS. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections, Overview and Estimates, 2001. Available at: http://www.who.int/emc-documents/STIs/ whocdscsredc200110c.html. Accessed February 3, 2004.
2. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163:233-239.
3. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95-102.
4. Martin HL Jr, Nyange PM, Richardson BA, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998; 178:1053-1059.
5. Cottingham J, Hunter D. Chlamydia trachomatis and oral contraceptive use: A quantitative review. Genitourin Med 1992; 68:209-216.
6. Louv WC, Austin H, Perlman J, et al. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 1989; 160:396-402.
7. Avonts D, Sercu M, Heyerick P, et al. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: A prospective study. Sex Transm Dis 1990; 17:23-29.
8. Rahm VA, Odlind V, Pettersson R. Chlamydia trachomatis in sexually active teenage girls. Factors related to genital chlamydial infection: A prospective study. Genitourin Med 1991; 67:317-321.
9. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol 2001; 185:380-385.
10. Singer A. The cervical epithelium during puberty and adolescence. In: Jordan JA, Singer A, eds. The Cervix. London: WB Saunders Co, 1976:87-97.
11. Goldacre MJ, Loudon N, Watt B, et al. Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. BMJ 1978; 1:748-750.
12. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, et al. Determinants of cervical ectopia and of cervicitis: Age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol 1995; 173:534-543.
13. Chacko MR, Lovchik JC. Chlamydia trachomatis infection in sexually active adolescents: Prevalence and risk factors. Pediatrics 1984; 73:836-840.
14. Toon PG, Arrand JR, Wilson LP, et al. Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. BMJ (Clin Res Ed) 1986; 293:1261-1264.
15. Plourde PJ, Pepin J, Agoki E, et al. Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis 1994; 170:313-317.
16. Collier AC, Handsfield HH, Ashley R, et al. Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J Infect Dis 1995; 171:33-38.
17. Morrison CS, Bright P, Blumenthal PD, et al. Computerized planimetry versus clinical assessment for the measurement of cervical ectopia. Am J Obstet Gynecol 2001; 184:1170-1176.
18. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, release 7.5. Research Triangle Park, NC: Research Triangle Institute, 1977.
19. Andersen PK, Gill RD. Cox's regression model for counting processes. Ann Stat 1982; 10:1100-1120.
20. SAS/STAT User's Guide, version 8. Cary, NC: SAS Institute Inc, 1999.
21. Jacobson DL, Peralta L, Farmer M, et al. Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents. Sex Transm Dis 2000; 27:313-319.
22. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance HIV vaginal transmission and early virus load. Nat Med 1996; 2:1084-1089.
23. Miller L, Patton DL, Meier A, et al. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 2000; 96:431-439.
24. Bahamondes L, Trevisan M, Andrade L, et al. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera. Contraception 2000; 62:23-27.
25. Mauck CK, Callahan MM, Baker J, et al. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception 1999; 60:15-24.
26. Donders G, De Wet HG, Hooft P, et al. Lactobacilli in Papanicolaou smears, genital infections, and pregnancy. Am J Perinatol 1993; 10:358-361.
27. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS 1998; 12:1699-1706.
28. Sonnex C. Influence of ovarian hormones on urogenital infection. Sex Transm Infect 1998; 74:11-19.
29. Schuurs A, Geurts T, Goorissen E. Immunologic effects of estrogens, progestins, and estrogen-progestin combinations. In: Goldzieher J, Fotherby K, eds. Pharmacology of the Contraceptive Steroids. New York: Raven Press, 1994:379-399.